Welcome to our dedicated page for Bath & Body Works SEC filings (Ticker: BBWI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bath & Body Works, Inc. filings document the public-company record for a Delaware specialty retailer whose common stock trades on the New York Stock Exchange under BBWI. Recent 8-K reports furnish quarterly and full-year operating results, earnings guidance, Regulation FD disclosures, debt redemption notices and executive officer changes.
Proxy materials describe board oversight, director elections, executive compensation, shareholder voting matters and governance practices tied to the company’s Consumer First Formula, brand, product, supply chain and store assets. The filings also identify registered common stock, senior notes disclosures and capital-structure matters for a personal care and home fragrance retail business.
Bath & Body Works reported lower Q1 2026 sales but higher GAAP profit driven by one-time items. Net sales were $1,378 million, down 3.2% from $1,424 million a year earlier, with softer U.S. and Canada store and direct sales partly offset by 9.0% growth in International and Other.
Gross profit fell to $587 million from $646 million, and the gross margin declined to 42.6% from 45.4%, reflecting tariffs, inflation, crude oil impacts and mix. GAAP net income rose to $183 million (diluted EPS $0.90) from $105 million ($0.49) largely due to an $88 million interchange fee settlement gain and a $62 million tax benefit.
On an adjusted basis, which excludes these items and other non-recurring gains and charges, net income declined to $65 million and adjusted diluted EPS to $0.32, versus $105 million and $0.49 in Q1 2025. Adjusted operating income fell to $151 million from $209 million. The company generated $244 million in operating cash flow, repaid $284 million of 2027 notes via a make-whole call, ending the quarter with $820 million in cash and $3,613 million in total debt and $544 million of undrawn ABL availability.
Bath & Body Works reported first quarter 2026 results that beat its own guidance while remaining below prior-year levels on an adjusted basis. Net sales were $1.378 billion, down 3% from $1.424 billion a year earlier. Reported diluted EPS rose to $0.90 from $0.49, but after excluding one-time items, adjusted diluted EPS was $0.32 versus $0.49 last year.
Operating income increased to $231 million from $209 million, or $151 million on an adjusted basis. The company reaffirmed full-year 2026 guidance for net sales to decline 4.5% to 2.5% and guided adjusted EPS to $2.40–$2.65, below 2025’s adjusted $3.21, with forecast free cash flow of about $600 million. Chief Financial Officer Eva Boratto will leave on June 12, 2026, and long-time executive Tom Javitch will serve as interim CFO while a search for a permanent successor is underway.
Bath & Body Works, Inc. Chief Supply Chain Officer Thomas E. Mazurek reported routine equity compensation activity. On May 19, 2026, he received 6,616 shares of common stock at $0.00 per share as a grant tied to the vesting of performance stock units originally granted on May 19, 2023. On the same date, 4,127 shares at $16.11 per share were withheld to cover tax withholding obligations related to the vesting of performance and restricted stock units. Following these transactions, he directly holds 119,297.404 shares of Bath & Body Works common stock.
Bath & Body Works, Inc. CEO Daniel Heaf reported a routine tax-related share disposition. On May 16, 2026, 7,334 shares of common stock were withheld at $17.09 per share to cover tax obligations tied to vesting restricted stock units. Following this non-market transaction, he directly holds 288,249 shares of common stock.
Vanguard Capital Management reported beneficial ownership of 10,720,033 shares of Bath & Body Works Inc. common stock, equal to 5.32% of the class. The filing states Vanguard has sole dispositive power over 10,720,033 shares and sole voting power over 1,563,043 shares.
Bath & Body Works Inc ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 15,164,483 shares of Common Stock, representing 7.53% of the class. The filing states Vanguard has sole dispositive power over 15,164,483 shares and sole voting power for 142,716 shares.
Bath & Body Works, Inc. is asking shareholders to approve ten director nominees, ratify its auditor and support an advisory vote on executive pay at a virtual annual meeting on June 11, 2026. The proxy describes a major strategic shift under new CEO Daniel Heaf, centered on the multi‑year Consumer First Formula to create disruptive products, reignite the brand, win in the marketplace and operate with greater speed and efficiency.
The company highlights a loyalty base of 40 million members, about 2,500 stores worldwide and its Fuel for Growth program, targeting $250 million of cost savings over two years, including $175 million in 2026. In fiscal 2025, net sales were $7.3 billion, essentially flat year over year, with GAAP operating margin of 15.4%, GAAP diluted EPS of $3.11, adjusted EPS of $3.21 and free cash flow of $865 million.
The Board reports returning cash through $167 million in dividends and the repurchase of approximately 15 million shares for $400 million in 2025. Governance features include an independent chair, separation of Chair and CEO roles, 90% independent directors, annual elections, proxy access and the ability for 25% holders to call special meetings. Executive pay is positioned as strongly performance‑based; 2025 short‑term incentives paid out only on first‑half results at 32.2% of target, with no year‑end payout after full‑year performance fell below threshold, while say‑on‑pay support reached 98.8%.
FMR LLC reports beneficial ownership of 20,867,399.55 shares of Bath & Body Works Inc. The filing (Schedule 13G/A, amendment) shows FMR LLC (and Abigail P. Johnson in related capacity) holds 20,867,399.55 shares, representing 10.4% of common stock as disclosed with a 03/31/2026 reference and signatures dated 04/06/2026.
The filing states voting and dispositive power figures on the cover: sole voting power and sole dispositive power consistent with the reported amount. An Exhibit reference describes a 13d-1(k)(1) agreement; further subsidiary detail is attached as Exhibit 99.
The Vanguard Group amended its Schedule 13G filing for Bath & Body Works Inc, reporting beneficial ownership of 0 shares (0%). The amendment notes an internal realignment effective January 12, 2026 and states certain Vanguard subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538.
The filing is labeled Amendment No. 14 and is signed on 03/26/2026. It lists sole and shared voting and dispositive powers as 0 for the class of common stock.